Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate CancerShusuke Akamatsu, Osamu Ogawa, Masashi Kubota et al.|European Urology Oncology|2018Cited by 55
The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysisTakuma Narita, Chikara Οhyama, Takuya Koie et al.|Medical Oncology|2016Cited by 49
Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in JapanShintaro Narita, Tomonori Habuchi, Shingo Hatakeyama et al.|International Journal of Clinical Oncology|2020Cited by 29
Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration‐sensitive prostate cancer: A multicenter retrospective studyShingo Hatakeyama, Chikara Οhyama, Toshihiko Sakurai et al.|International Journal of Urology|2020Cited by 28
Impact of Nerve-Sparing Status on Positive Surgical Margin Location and Biochemical Recurrence in Patients with Prostate Cancer Post Radical ProstatectomyYoshinori Matsuda, Tomonori Habuchi, Shintaro Narita et al.|Annals of Surgical Oncology|2021Cited by 12